Journal
IMMUNITY
Volume 52, Issue 5, Pages 753-766Publisher
CELL PRESS
DOI: 10.1016/j.immuni.2020.04.008
Keywords
-
Categories
Funding
- Doris Duke Charitable Foundation
- LEO Pharma
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health [R01AR070116]
Ask authors/readers for more resources
Although the medical definition of itch has been in existence for 360 years, only in the last 20 years have we begun to understand the basic mechanisms that underlie this unique sensation. Therapeutics that specifically target chronic itch as a pathologic entity are currently still not available. Recent seminal advances in itch circuitry within the nervous system have intersected with discoveries in immunology in unexpected ways to rapidly inform emerging treatment strategies. The current review aims to introduce these basic concepts in itch biology and highlight how distinct immunologic pathways integrate with recently identified itchsensory circuits in the nervous system to inform a major new paradigm of neuroimmunology and therapeutic development for chronic itch.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available